This Solicitation opportunity from Department Of Health And Human Services was posted on June 14, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Drug Target Analysis in the Human Central Nervous System

Closed

FDASBRFP75F40124Q00344Federal

Submission Closed07/07/2024, 02:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714

New

Federal

REGAGENTS TEST KITSThe United States Department of the Naval Medical Research Command is procuring specialized reagent kits and consumables from Illumina Inc. under a non-competitive contract based on sole-source authority for brand-name equipment. The requirement includes a comprehensive list of Illumina products essential for respiratory pathogen detection and genomic analysis, such as multiple sets of Respiratory Virus Enrichment Kits, Respiratory Pathogen ID/AMR Enrichment Kits, DNA/RNA UD Indexes, XLEAP-SBS and MiSeq reagent kits, and the PhiX Control v3. These materials are critical for high-throughput sequencing and molecular surveillance activities conducted by the military medical research community. All items are designated for research use only, with specific catalog numbers clearly identified to ensure exact product alignment. procurement is governed under FAR Part 12 as a commercial item acquisition, with the NAICS code 541714 assigned to laboratory research and development services. Vendors must be registered in the System for Award Management and possess a Unique Entity Identification Number to be eligible for award, with no exceptions permitted. The solicitation number is N3239826Q4854, with responses due by July 17, 2026, and all proposals should be directed to the designated point of contact at the Naval Medical Research Center in Silver Spring, Maryland. While this is not a competitive solicitation, the government will evaluate capability statements submitted by interested parties to confirm suitability and compliance with operational needs.

Naval Medical Research Center

POSTED

DEADLINE

Advancing Autonomous Science for Biological Applications RFIThe Defense Advanced Research Projects Agency’s Biological Technology Office is soliciting input from the scientific and technical community to assess the current state of autonomous science in biological applications and identify high-potential opportunities for investment. This request for information aims to guide future research and development priorities that align with national security objectives and broader public benefit, with a focus on technologies that enable machines to independently design, execute, and interpret biological experiments without direct human intervention. Responses are requested by July 22, 2026, and should address advancements in automation, artificial intelligence, robotics, and data integration within biological research domains. All submissions must be directed to Dr. Russell Schwartz, Program Manager at DARPA/BTO, via the email AutoSci-RFI@darpa.mil, and the opportunity is classified under NAICS code 541714 for Research and Development in the Physical, Engineering, and Life Sciences. The request is open to the public with no set-aside requirements, and responses will inform potential future funding initiatives rather than constitute a solicitation for immediate contracts. Interested parties are encouraged to provide detailed technical insights, emerging innovations, and challenges in autonomous biological science to help shape the agency’s strategic investments in this rapidly evolving field.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Vector-borne Disease Agent Surveillance Research & Development in External Proficiency TestingThe contract seeks a Firm-Fixed Price award for research, development, and validation of field-expedient external proficiency testing procedures to detect pathogens in arthropods, specifically mosquitoes, using non-infectious agents to minimize risk and ensure safety. The work, titled Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing, is managed by the Defense Health Agency under the Department of Defense and is assigned NAICS code 541714 for Research and Development in Biotechnology. The performance period spans one year from September 30, 2026, to September 29, 2027, with key deliverables including a kickoff meeting within 15 days of award, a draft and final written manual for safe proficiency testing, a comprehensive validation report documenting accuracy, precision, analytical sensitivity, and specificity, and a results package with statistically valid data from at least 60 samples. All work is unclassified, with Controlled Unclassified Information (CUI) handling applicable, while Personally Identifiable Information and Protected Health Information requirements do not apply. The Government intends to obtain unlimited rights in all data and deliverables to support force health protection and potential transition to other entities. Submissions must be structured into two volumes: Volume I, the Technical Capabilities section, limited to ten pages, detailing technical expertise in external quality assurance, quality control measures, sourcing, delivery approach, and schedule adherence; and Volume II, the Price section, with no page limit but requiring unit and total prices for the single contract line item. Quotes must be submitted electronically by June 16, 2026, in Word, Excel, or searchable PDF format, with zip files prohibited. Offerors must maintain active SAM registration and submit completed provisions 52.219-1 and 252.204-7017. Technical proposals must achieve at least an "Acceptable" rating and the proposed price must be deemed complete and reasonable as mandatory pass/fail gates; award will be made based on the most advantageous offer considering both technical merit and price, without negotiations. Contract administration relies on the Wide Area WorkFlow system for payments, with tailored instructions for cost-type and fixed-price deliverables, and is governed by a Quality Assurance Surveillance Plan that defines performance standards, surveillance frequency, and defect thresholds. The Contracting Officer’s Representative provides oversight but lacks authority to modify contract terms. Compliance with clauses on convict labor, prohibitions on inverted corporations, confidentiality agreements, trafficking in

Defense Health Agency

POSTED

DEADLINE

Notice of Intent contact activation pathway function blocking antibody AB023The Defense Health Agency, through its Contracting Activity, intends to award a sole-source contract to Oregon Health & Science University for the supply of the contact activation pathway function blocking antibody AB023, in support of the United States Army Institute of Surgical Research. This determination follows a prior Request for Information that received no responses, leading the government to conclude that OHSU is the only viable source capable of fulfilling this specialized requirement. The contract action is classified under NAICS code 541714, which pertains to research and development in the physical, engineering, and life sciences, with a size standard of 1,000 employees. The solicitation number is HT9426-26-NOI-WS03, and while this notice is not a solicitation for competitive bids, responsible parties may still submit capability information by July 9, 2026, to demonstrate their ability to meet the requirement, though such submissions will only inform the government’s decision on competitiveness and carry no cost reimbursement. All submissions must be sent via email to the designated point of contact by the deadline, and the government retains full discretion to proceed with non-competitive award. The primary performance location is in San Antonio, Texas, while the contracting office is based in Fort Detrick, Maryland.

Defense Health Agency

POSTED

DEADLINE

Site-Specific Clinical Research Study ExecutionThe contract requires the design and execution of a focused clinical research project examining outcomes related to spinal cord injury in the domains of health, employment, or community living. The awardee must obtain IRB approval, recruit eligible participants, deliver the assigned intervention, and systematically measure outcomes using validated methods. This work is conducted as a subcontract under the Administration for Community Living within the Department of Health and Human Services and is aligned with research priorities aimed at improving quality of life for individuals with spinal cord injuries. All activities must adhere to ethical standards and federal research guidelines, with full responsibility for study implementation resting with the contractor. The project is governed under NAICS code 541714, indicating a focus on research and development in the social sciences and humanities. The solicitation was posted on June 22, 2026, with responses due by July 29, 2026. There is no set-aside designation specified, and the place of performance details are not provided, implying flexibility in location as long as the research objectives are met. The award is structured as a subcontract, suggesting it supports broader federal efforts to advance SCI recovery and integration outcomes. The contractor must demonstrate capacity in human subjects research, clinical study logistics, and outcome measurement to successfully fulfill the scope.

Administration For Community Living

POSTED

3 days ago

DEADLINE

in about 1 month

General Info

Agency

Department Of Health And Human Services → FDA National Center For Toxicological ResearchView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Set-Aside

SBA

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedJun 14

Solicitation

Response DeadlineJul 7

Deadline has passed

Submission Closed

07/07/2024, 02:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → FDA National Center For Toxicological Research

Contacts1 person available

OfficeSilver Spring, MD, 20993, USA

Organization / Agency

Department Of Health And Human Services → FDA National Center For Toxicological Research

View Agency Profile

Office AddressSilver Spring, MD, 20993, USA

Contacts

Ryan Alexander

contact@example.gov

Full Description

Title: Drug Target Analysis in the Human Central Nervous System Questions are due1PM EST 06/26/2024 Proposals are due 1PM EST 07/07/204